Indian Journal of Obstetrics and Gynecology Research
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Original Article
Author Details :
Volume : 7, Issue : 3, Year : 2020
Article Page : 426-429
https://doi.org/10.18231/j.ijogr.2020.089
Abstract
Even today, polycystic ovary syndrome (PCOS) and its management remains a challenge. The entry of
innovative products in the clinical armamentarium for PCOS management is welcome and needs to be
investigated for their efficacy and safety in Indian women suffering from PCOS. This was a multicentric
postmarketing surveillance (PMS) study done in 457 women suffering from PCOS from all over India.
92 clinicians from 35 cities participated in this study. High ovulation (91%) and conception rate (67.8%)
was reported with this study product* (fixed-dose combination of myo-inositol 550 mg, D-chiro-inositol
13.8 mg, L-methyl folate 0.1 mg, vitamin D3 400 IU and chromium picolinate 100 mcg as orange-flavoured
chewable tablets) administered as one tablet twice daily for 3 months. Reduction in body mass index (BMI),
substantial decrease in serum testosterone and hirsutism, and an increase in serum progesterone were also
reported with the study product. As a first-line management for PCOS, the fixed-dose combination of myoinositol
550 mg, D-chiro-inositol 13.8 mg, L-methyl folate 0.1 mg, vitamin D3 400 IU and chromium
picolinate 100 mcg as orange-flavoured chewable tablets, therefore, shows strong promise.
Keywords: Polycystic ovary syndrome, PCOS, Myo-inositol, D-chiro-inositol, Insulin resistance, Infertility, Anovulation, Hyperandrogenism
How to cite : Gawade B , Hegde R , Indian clinical experience on an innovative product in the management of polycystic ovary syndrome. Indian J Obstet Gynecol Res 2020;7(3):426-429
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
